LPLivio Presutti

Livio Presutti

*This is an algorithmically generated author record based on publicly available information.

Livio Presutti has a total of 177 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Use of the ORBEYE™ Exoscope for the Treatment of Presumed Postoperative Cholesteatoma of the External Auditory Canal: A Case Report

    by Carlotta Liberale, Arianna Burato, Livio Presutti, Giuseppe Mercante, Giulia Molinari

    Background/Objectives: To describe the technical feasibility of fully exoscopic management of an unusually extensive external auditory canal cholesteatoma (EACC). Methods: We report a 26-year-old man with advanced right EACC and a history of ipsilateral myringoplasty approximately 15 years previously; a postoperative origin was suspected but could not be established. Clinical, radiological, surgical, and follow-up findings are described. Results: Imaging revealed extensive erosion of the superior EAC and adjacent temporal bone with mass effect on the right temporal lobe. The ORBEYE™ 4K three-dimensional exoscope was used throughout the operation, including dissection along exposed dura and hearing-preserving reconstruction. An intraoperative cerebrospinal fluid leak occurred at the middle cranial fossa dura and was controlled during surgery, without persistent postoperative leakage. The patient was discharged on postoperative day 4. Based on the reported four-frequency pure-tone averages, the calculated air–bone gap decreased from 18.5 to 8.5 dB HL. Diffusion-weighted MRI at 18 months showed no evidence of residual or recurrent disease, and clinical examination at 24 months showed a patent, epithelialized canal. Conclusions: This case illustrates the technical feasibility of a fully exoscopic, hearing-preserving approach to complex EACC. Comparative studies are required before conclusions about superiority or generalizable safety relative to conventional visualization can be drawn.

  • Open Access

    Drug–Drug Interactions in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated with Immunotherapy: A Multicenter Cohort Study

    by Alessio Cirillo, Daria Filippini, Giulia Fiscon, Lorenzo Farina, Davide Smussi, Claudia Assoni, Andrea Alberti, Elisabetta Nobili, Filippo Valentini, Sofia Scandolara, et al.

    Background Drug-drug interactions (DDIs) are an emerging issue in oncological patients, given the risk of increased toxicities and reduced efficacy from oncological treatments. This is particularly relevant in recurrent-metastatic (RM) head and neck cancer (HNC), where patients are often older, multimorbid, and receiving multiple home medications. While most DDIs are known for chemotherapy and targeted therapies, data on immune checkpoint inhibitors (ICIs) remain limited. Therefore, RM HNC patients represent a target population to investigate DDIs effects on ICIs. Material and Methods We conducted a retrospective, multicenter study to evaluate if polypharmacy affected safety and efficacy in RM HNC patients treated with ICIs, given alone (pembrolizumab or nivolumab) or in combination (combo) with chemotherapy (pembrolizumab-platinum-5-fluoruracil). DDIs were assessed using the Drug-PIN® platform, which provides for each patient two parameters: a Drug-PIN score, i.e. a continuous variable - the greater the number, the greater the likelihood of DDI; and a Drug-PIN level, with 5 levels ranging from green, meaning no interaction found, to red, meaning high potential for interaction. The relationship between Drug-PIN parameters and immune-related adverse events (irAEs) was tested using Student’s t-test. The correlation between Drug-PIN parameters and patients’ survival was assessed with the Kaplan-Meier method. Results We analysed 180 RM HNC (128 males) patients treated between June 2017 and July 2022 with ICIs (49 pembrolizumab alone, 89 nivolumab alone, 42 combo) at three different institutions. The median age was 65 years old (range: 33-89). Every patient took a median of 5 medications (0-15). Median Charlson Comorbidity Index score was 8 (2-14). IrAEs of any grade were observed in 55 patients (31%). Median PFS and OS were 5.9 and 6.5 months for pembrolizumab alone, 7.8 and 11.1 months for combo, 5 and 11.4 months for nivolumab. Median Drug-PIN score was 39.4 (0-214,3); Drug-PIN levels were green, light yellow, dark yellow, orange and red in 56, 27, 32, 9, 56 pts, respectively. Dichotomizing patients according to median Drug-PIN score, no difference was found in irAEs incidence (p 0.48), PFS (p. 0.82), or OS (p 0.89). No differences in irAEs incidence or in survival outcomes could be elucidated by stratifying patients according to Drug-PIN levels. Conclusions ICIs safety and efficacy in the treatment of RM HNC seem not to be affected by polypharmacy and DDIs.

  • Open Access

    Surgical Management of Parapharyngeal Metastases from Thyroid Carcinoma: A Systematic Review and Patient-Level Analysis of the Role of Lateral Neck Dissection

    by Francesco Chiari, Marika Reppucci, Matteo Fermi, Giulia Di Dalmazi, Vincenzo Palatino, Daria Maria Filippini, Giovanni Motta, Giuseppe Mercante, Livio Presutti, Claudio Donadio Caporale, et al.

    Background/Objectives: Parapharyngeal space (PPS) metastases from thyroid carcinoma are rare, and evidence guiding their surgical management, particularly the role of concomitant lateral neck dissection (LND) in patients with a clinically node-negative (cN0) neck, remains limited. This systematic review and patient-level analysis evaluated the clinicopathological characteristics, surgical management, and oncologic outcomes of PPS metastases, with particular emphasis on the management of the cN0 neck. Methods: A PRISMA 2020-compliant systematic review of PubMed, Scopus, and the Cochrane Library was performed. Patient-level data were analyzed according to clinical neck status and timing of PPS metastasis presentation. Results: Thirty-two studies including 162 patients were analyzed. Papillary thyroid carcinoma accounted for 94.4% of cases, while PPS metastases presented as primary disease in 48.8% and recurrent disease in 51.2% of patients. The transcervical approach (TCA) was the predominant surgical technique (79.1%), whereas LND was performed in 70.2% of patients with available data. Among the 19 patients with a cN0 neck, 10 had a previously undissected lateral neck; of these, 6 underwent elective LND and 4 underwent isolated PPS metastasectomy. No occult cervical lymph node metastases were identified following elective LND. Patients with recurrent PPS metastases had significantly higher overall recurrence (47.5% vs. 13.2%, p < 0.001) and disease-specific mortality (22.8% vs. 5.6%, p = 0.003) than those with primary PPS metastases. Conclusions: TCA remains the reference surgical strategy for PPS metastases from thyroid carcinoma. Although based on a very limited cN0 subgroup, current evidence suggests that routine elective LND may not be necessary in carefully selected patients presenting with isolated PPS metastases and a cN0 neck. Recurrent PPS metastases are associated with poorer oncologic outcomes.

  • Open Access

    Pediatric Adenotonsillectomy over 20 Years in a High-Volume Italian Centre: Positive Outcomes with Low Complications—The Sassuolo Hospital Experience

    by Gennaro Confuorto, Renato Baldi, Elisa Cigarini, Giorgio Di Lorenzo, Silvia Menabue, Federico Spagnolo, Margherita Trani, Massimo Zanni, Livio Presutti, Daniele Marchioni, et al.

    Background: Pediatric adenotonsillectomy is commonly performed for infectious and obstructive indications, but postoperative hemorrhage remains a concern. This study describes outcomes from a high-volume territorial network in southern Modena province, Italy. Methods: Retrospective observational study of 10,753 pediatric patients (aged 3–18 years) undergoing adenotonsillectomy at Sassuolo Hospital and affiliates (Vignola, Pavullo) from 2005 to 2024. Indications included recurrent tonsillitis (Paradise criteria), obstructive sleep apnea (OSA) (polysomnography-confirmed or clinical), and recurrent otitis media or otitis media with effusion (OME). Surgical techniques included curettage adenoidectomy and Colorado microdissection needle tonsillectomy. Our institutional postoperative care protocol included analgesics, oral hydration, soft diet, antibiotics (amoxicillin) and scheduled follow-up; however, no analysis regarding this protocol was intended to demonstrate correlations with study outcomes. Primary outcomes were postoperative hemorrhage (overall and requiring revision), stratified by indication, age, and technique, and contextualized against ranges reported in large published cohorts (qualitative, exploratory comparison). Secondary outcomes included pain (VAS scores), infection rates, and tissue regrowth. Data completeness was verified via electronic records (95.6%). Statistical analyses used descriptive statistics with 95% confidence intervals (95% CI) and inferential tests for within-cohort comparisons (χ2 tests, Fisher’s exact test, and t-tests where appropriate). Results: A total of 10,753 procedures were analyzed (4325 tonsillectomies, 3942 adenotonsillectomies, 2486 adenoidectomies). Postoperative hemorrhage occurred in 202 patients (1.88%; 95% CI 1.64–2.15%); surgical revision was required in 75 (0.70%; 95% CI 0.56–0.87%), with multifactorial stratification showing higher risk for infectious indications (OR 1.41 vs. OSA), younger age < 5 years (OR 2.1), and tonsillectomy origin (OR 8.25 vs. adenoidectomy); all rates are at the lower end of literature ranges (2–5% and 0.9–2.5%, respectively), in line with large published cohorts, although these comparisons are qualitative and exploratory. Mean VAS pain scores decreased from 3.2 (day 1) to 1.1 (day 7). No significant infections occurred; tissue regrowth rates aligned with the literature (adenoidal 6–26%, tonsillar 5–10%). Conclusions: Sassuolo Hospital’s experience highlights favorable postoperative outcomes and low complication rates in adenotonsillar surgery. Limitations include the retrospective design, potential selection bias and long period evaluation. Prospective studies are needed to confirm these findings.

  • Open Access

    Pediatric Adenotonsillectomy over 20 Years in a High-Volume Italian Centre: Positive Outcomes with Low Complications – The Sassuolo Hospital Experience

    by Gennaro Confuorto, Renato Baldi, Elisa Cigarini, Giorgio Di Lorenzo, Silvia Menabue, Federico Spagnolo, Margherita Trani, Massimo Zanni, Livio Presutti, Daniele Marchioni, et al.

    BackgroundPediatric adenotonsillectomy is commonly performed for infectious and obstructive indications, but postoperative hemorrhage remains a concern. This study describes outcomes from a high-volume territorial network in southern Modena province, Italy.Methods: Retrospective observational study of 10,753 pediatric patients (aged 3–18 years) undergoing adenotonsillectomy at Sassuolo Hospital and affiliates (Vignola, Pavullo) from 2005–2024. Indications included recurrent tonsillitis (Paradise criteria), OSA (polysomnography-confirmed or clinical), and recurrent otitis media or otitis media with effusion (OME). Surgical techniques included curettage adenoidectomy and Colorado microdissection needle tonsillectomy. Primary outcomes were postoperative hemorrhage (overall and requiring revision), stratified by indication, age, and technique, compared descriptively with literature ranges. Secondary outcomes included pain (VAS scores), infection rates, and tissue regrowth. Data completeness was verified via electronic records (95.6%). Statistical analyses used descriptive statistics with 95% confidence intervals (95% CI) and χ² tests. Results: A total of 10,753 procedures were analyzed (4,325 tonsillectomies, 3,942 adenotonsillectomies, 2,486 adenoidectomies). Postoperative hemorrhage occurred in 202 patients (1.88%; 95% CI 1.64–2.15%); surgical revision was required in 75 (0.70%; 95% CI 0.56–0.87%), with multifactorial stratification showing higher risk for infectious indications (OR 1.41 vs OSA), younger age <5 years (OR 2.1), and tonsillectomy origin (OR 8.25 vs adenoidectomy); all rates at the lower end of literature ranges (2–5% and 0.9–2.5%, respectively; both p < 0.001 vs. literature means, χ² test). Mean VAS pain scores decreased from 3.2 (day 1) to 1.1 (day 7). No significant infections occurred; tissue regrowth rates aligned with literature (adenoidal 6–26%, tonsillar 5–10%). Conclusions: Sassuolo Hospital's experience highlights favorable postoperative outcomes and low complication rates in adenotonsillar surgery. Limitations include retrospective design and potential selection bias. Prospective studies are needed to confirm these findings.

  • Open Access

    Endoscopic partial and total ossicular chain reconstruction in children: A multicentric study

    by Giulia Molinari, Raffael Fink, Nicola Bisi, Sven Beckmann, Arianna Burato, Daniele Marchioni, Livio Presutti, Ignacio Javier Fernandez, Lukas Anschuetz


  • Open Access

    Endoscopic ossiculoplasty: audiological and surgical outcomes from a multicenter experience with 292 cases

    by Raffael Fink, Giulia Molinari, Arianna Burato, Daniel Stricker, Nicola Bisi, Daniele Marchioni, Livio Presutti, Ignacio Javier Fernandez, Lukas Anschuetz

    Purpose: To evaluate surgical and audiological outcomes of different endoscopic ossiculoplasty (endo-OPL) techniques and prosthesis materials. Methods: In this multicenter retrospective study, 292 patients underwent endo-OPL for various ossicular chain pathologies at three university hospitals between 2017 and 2023. We analyzed pre- and postoperative hearing metrics, perforation characteristics, surgical procedures, prosthesis types, and complication rates. Results: The cohort showed significant audiological improvement, with the mean preoperative air-bone gap (ABG) reducing from 26.88 dB (SD ± 12.73) to 19.94 dB (SD ± 10.90) at the last follow-up (FU; mean 20.7 months ± 15.53) ( p = 0.001), and a graft success rate of 94.2%. Significant postoperative ABG improvements were observed with bony partial ossicular replacement prostheses (PORP) ( p < 0.001), titanium total ossicular replacement prostheses (TORP) ( p = 0.008), and semi-synthetic TORP ( p = 0.016). Both cement PORP and bony PORP groups showed consistent ABG improvements over two FU visits. Conversely, titanium based PORP and TORP demonstrated initial improvements but later showed deterioration. Prosthesis extrusion and dislocation rates were 8.4% and 4.2% for titanium PORP, and 0% and 5.2% for titanium TORP, respectively, at the last FU. Endo-OPL combined with additional mastoidectomy ( n = 59) did not yield significant ABG improvements. Conclusion: This multicenter study supports the efficacy of endo-OPL as a valuable technique to improve hearing outcomes in patients with conductive or mixed hearing loss. It highlights the superior performance of specific prosthesis materials and demonstrates that endo-OPL without additional mastoidectomy provides better hearing results, emphasizing the benefits of mastoid preservation in exclusive endoscopic procedures.


  • Open Access

    A Novel 3D-Printed Training Platform for Ossiculoplasty with Objective Performance Evaluation

    by Nicolas Emiliani, Giulia Molinari, Barbara Bortolani, Cecilia Lotto, Arianna Burato, Rossana D’azzeo, Lukas Anschuetz, Ignacio Javier Fernandez, Livio Presutti, Gabriele Molteni, et al.

    Ossiculoplasty (OPL) aims to restore ossicular chain continuity to improve hearing in patients with conductive or mixed hearing loss, often performed during tympanoplasty. The current training methods, including cadaveric temporal bone models, face challenges such as limited availability, high costs, and biological risks, prompting the exploration of alternative models. This study introduces a novel training platform for OPL using 3D-printed temporal bones and incudes, including a magnified (3:1) model to enhance skill acquisition. Sixty medical students were divided into two groups: one trained on magnified models before transitioning to real-sized ones, and the other used only real-sized models. Training performance was quantitatively assessed using post-remodeling cone-beam CT imaging and mesh distance analysis. The results showed a significant improvement in performance for students with preliminary training on magnified models (87% acceptable results vs. 37%, p = 0.001). Qualitative feedback indicated higher confidence and skill ratings in the magnified model group. This study highlights the effectiveness of scalable, anatomically accurate synthetic models for complex surgical training. While further validation is required with experienced trainees and broader scenarios, the findings support the integration of 3D printing technologies into otologic education, offering a cost-effective, reproducible, and innovative approach to enhancing surgical preparedness.


  • Open Access

    Oncological and Functional Outcomes After Type III Cordectomy for Early Glottic Cancer (Tis, T1a): A Retrospective Study Based on Our 10-Year Experience

    by Eleonora Lovati, Elisabetta Genovese, Livio Presutti, Marco Trebbi, Luca Pingani, Gian Maria Galeazzi, Maria Pia Luppi, Matteo Alicandri-Ciufelli, Daniele Marchioni, Maria Consolazione Guarnaccia

    Background: The recommended treatment for early glottic cancer is trans-oral laser microsurgery, with excellent oncological and functional outcomes. The aim of this study is to evaluate oncological and functional outcomes in patients who underwent monolateral type III laser cordectomy for early glottic cancer. Methods: A total of 104 patients were enrolled. Staging, histological type, grading, assessment of surgical margins, mean time of relapse, OS, DFS, and DSS were obtained. Maximum phonation time, GIRBAS score, shimmer, jitter, fundamental frequency, and Yanagihara score were evaluated. Patients were submitted to the VHI-10 questionnaire. Results: Correlations between patients with single recurrence and the anterior commissure involvement were analyzed, as well as correlations between patients with recurrence and the status of margins. Correlations between VHI-10 scores and anterior commissure involvement were analyzed. Conclusions: The recurrence rate was higher in patients with anterior commissure involvement. A significant inversely proportional association between DSS and assessment of surgical margins was observed. The distribution of VHI-10 scores differed significatively in patients with and without anterior commissure involvement. Vocal results reflected mild dysphonia.


  • Open Access

    Rare Head and Neck Cancers and Pathological Diagnosis Challenges: A Comprehensive Literature Review

    by Daria Maria Filippini, Francesca Carosi, Giulia Querzoli, Matteo Fermi, Ilaria Ricciotti, Gabriele Molteni, Livio Presutti, Maria Pia Foschini, Laura Deborah Locati

    Head and neck cancers (HNCs) arise from anatomically adjacent sites and subsites, with varying etiological factors, diagnostic strategies, prognoses, and treatment approaches. While conventional squamous cell carcinoma (SCC) is the most common histology in the head and neck district, HNCs encompass a variety of rare histopathological entities, categorized into epithelial tumors such as salivary gland cancers, sinonasal tumors, neuroendocrine tumors, malignant odontogenic tumors, and SCC variants versus non-epithelial tumors including soft tissue sarcomas, mucosal melanomas, and hematological malignancies. Rare HNCs (R-HNCs) represent a diagnostic and clinical challenge, requiring histopathological expertise, the availability of peculiar molecular analysis, and the personalization of local and systemic treatments, all guided by a multidisciplinary tumor board. Here, we provide a comprehensive literature review on R-HNCs, emphasizing key histopathological and molecular characteristics that are crucial for guiding treatment decisions. An insight about the latest developments in systemic treatments is also reported.